Responses of metastatic primary fallopian tube carcinoma to pembrolizumab and nab-paclitaxel: A case report

RATIONALE: Primary fallopian tube carcinoma (PFTC) is an extremely rare but invasive malignancy with a dismal prognosis. Very few data exist on the salvage treatment for patients with PFTC. Here we report a case showing an impressive response to immunotherapy combined with chemotherapy, which have n...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jian, Chen, Zhi-peng, Zhu, Hui-ping, Zhang, Yong-qin, Qian, Xiao-lan, Zhang, Min, Ni, Chen, Zuo, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360280/
https://www.ncbi.nlm.nih.gov/pubmed/32664168
http://dx.doi.org/10.1097/MD.0000000000021203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360280/
https://www.ncbi.nlm.nih.gov/pubmed/32664168
http://dx.doi.org/10.1097/MD.0000000000021203

Ejemplares similares